Do you plan to incorporate fish-oil supplementation into the care of hemodialysis patients to reduce cardiovascular events in light of the PISCES trial results?  

I showed the paper to an Internal Medicine friend of mine who is more statistically savvy than me. He wrote this: "So I read the study, and I’m still at a loss to understand it. I’m pretty Bayesian, but this study breaks my priors. Prior studies were basically negative, not to mention ...

Not yet. I like to see more data. I believe the fish oil trials in cardiovascular population have not had positive results in the general population. I don't believe ESRD patient follow different rules than the rest of us.